65,437 trials
Family Caregiver · Dementia · Peer Support
Primary: Medical Outcomes Study Social Support Survey (MOS SSS) — 3.75; 3.79; 3.68; 3.50 score on a scale
IgA Nephropathy · Lupus Nephritis · Membranous Nephropathy
Primary: Part A: Change From Baseline in Proteinuria at Week 48 — -0.1364; 0.3560; 0.3430; -2.0347 ratio
Healthy
Primary: Gonadotropin Suppression — 16; 1 Participants — p=0.003
Hearing Loss
Primary: Monosyllabic Word in Quiet Scores. — 51; 51.25; 48.50 Percentage of words repeated correctly
Knee Osteoarthritis
Primary: Change From Baseline in Knee Pain Measured by Numeric Pain Rating Scale — -0.2; -0.5; -0.1 units on a scale
Diabetes Mellitus · High Blood Pressure · High Blood Sugar
Primary: Change From Baseline in Patient Glycemic Control at 6 Months — -0.43; -0.97 percentage — p=0.07
Electronic Cigarette Use
Primary: Effort for Product Puffs With Cross Product Progressive Ratio Task (CP-PRT) — 6.30; 6.38; 6.34; 5.94 Breakpoint (highest trial completed)
Cystic Fibrosis
Primary: Pulmonary Function Testing — 1.9; 2.0 L/sec
Pulmonary Arterial Hypertension · Familial Primary Pulmonary Hypertension · Primary Pulmonary Hypertension
Primary: Plasma Carnitine Concentration — 44 uM
Overweight and Obesity
Primary: Change in Preference- Liking — 6.5; 4.5 units on a scale
Melanoma
Primary: Evaluate Compliance With Standard High Dose Interferon (HDI) Versus Sylatron — 10; 38 number of doses taken
Type 2 Diabetes
Primary: Hemoglobin A1c — 7.004; 6.24; 6.47 percentage of hemoglobin
Alcohol Use Disorder · Nicotine Use Disorder
Primary: Brain Activation During Functional Magnetic Resonance Imaging (fMRI) in Response to a Stress Modulated Cue Induced Craving Task (DSNBACK) — -26.1562; -45.2123; 18.4989…
Cigarette Smoking
Primary: Psychosocial Expectancies (PROMIS Smoking Initiative) Patient Reported Outcome — 12.7; 13.6 score on a scale — p=0.17
Cystic Fibrosis
Primary: Decrease in FEV0.5 After Inhalation of Hypertonic Saline — 0 participants